What is the current status of precision medicine

Date 11 September 2017
Event ESMO 2017 Congress
Session Impact of tumour heterogeneity on precision medicine in kidney and bladder cancers
Topics Genitourinary Cancers
Personalised Medicine
Presenter Christophe Massard
Authors C. Massard
  • Drug Development Department (ditep), Gustave Roussy Cancer Campus, 94805 - Villejuif/FR